Clinical Trials Directory

Trials / Completed

CompletedNCT04174443

The Efficacy and Safety of Pulsed Radiofrequency Combined With Continuous Radiofrequency for the Trigeminal Neuralgia

The Efficacy and Safety of the Application of Pulsed Radiofrequency, Combined With Low-temperature Continuous Radiofrequency, to the Gasserian Ganglion for the Treatment of Primary Trigeminal Neuralgia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
146 (actual)
Sponsor
Beijing Tiantan Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Trigeminal neuralgia is a very painful condition, and radiofrequency therapy is reserved for patients who are resistant or intolerant to pharmacological therapy. Continuous radiofrequency and pulsed radiofrequency both have advantages and disadvantages. Recently, studies have found that pulsed radiofrequency combined with low-temperature (\<65 °C) continuous radiofrequency increases the efficacy of the treatment, without leading to a significant increase in complications caused by nerve lesions. However, these reports have some limitations. The investigators plan to conduct a randomized, controlled study to compare the efficacy of applying high-voltage pulsed radiofrequency, with and without low-temperature continuous radiofrequency, to the gasserian ganglion for the treatment of trigeminal neuralgia. The primary outcome will be the effectiveness of the treatment after 12 months which is the percentage of participants with a modified Barrow Neurological Institute Pain Intensity Score between I-III.

Conditions

Interventions

TypeNameDescription
PROCEDUREHigh-voltage pulsed radiofrequency2 Hz of pulsed radiofrequency will be administered at a voltage of 70 V, temperature of 42 °C, pulse width of 20 ms, and treatment time of 600 s.
PROCEDURELow-temperature continuous radiofrequencyLow-temperature continuous radiofrequency will be performed at 60 °C, with a treatment time of 270 s.

Timeline

Start date
2020-12-02
Primary completion
2022-10-26
Completion
2022-10-26
First posted
2019-11-22
Last updated
2024-08-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04174443. Inclusion in this directory is not an endorsement.